• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Public Health . Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-

tetano

Editor, Senior Moderator
BMC Public Health


. 2024 Feb 6;24(1):395.
doi: 10.1186/s12889-024-17747-z. Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity

Samar Sami Alkafaas[SUP] 1 [/SUP], Abanoub Mosaad Abdallah[SUP] 2 [/SUP], Mai H Hassan[SUP] 3 [/SUP], Aya Misbah Hussien[SUP] 4 [/SUP], Sara Samy Elkafas[SUP] 5 6 [/SUP], Samah A Loutfy[SUP] 7 8 [/SUP], Abanoub Mikhail[SUP] 9 10 [/SUP], Omnia G Murad[SUP] 11 [/SUP], Mohamed I Elsalahaty[SUP] 11 [/SUP], Mohamed Hessien[SUP] 3 [/SUP], Rami M Elshazli[SUP] 12 [/SUP], Fatimah A Alsaeed[SUP] 13 [/SUP], Ahmed Ezzat Ahmed[SUP] 14 [/SUP], Hani K Kamal[SUP] 15 [/SUP], Wael Hafez[SUP] 16 17 [/SUP], Mohamed T El-Saadony[SUP] 18 [/SUP], Khaled A El-Tarabily[SUP] 19 [/SUP], Soumya Ghosh[SUP] 20 21 [/SUP]



Affiliations
Free article Abstract

Recently, COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, caused > 6 million deaths. Symptoms included respiratory strain and complications, leading to severe pneumonia. SARS-CoV-2 attaches to the ACE-2 receptor of the host cell membrane to enter. Targeting the SARS-CoV-2 entry may effectively inhibit infection. Acid sphingomyelinase (ASMase) is a lysosomal protein that catalyzes the conversion of sphingolipid (sphingomyelin) to ceramide. Ceramide molecules aggregate/assemble on the plasma membrane to form "platforms" that facilitate the viral intake into the cell. Impairing the ASMase activity will eventually disrupt viral entry into the cell. In this review, we identified the metabolism of sphingolipids, sphingolipids' role in cell signal transduction cascades, and viral infection mechanisms. Also, we outlined ASMase structure and underlying mechanisms inhibiting viral entry 40 with the aid of inhibitors of acid sphingomyelinase (FIASMAs). In silico molecular docking analyses of FIASMAs with inhibitors revealed that dilazep (S = - 12.58 kcal/mol), emetine (S = - 11.65 kcal/mol), pimozide (S = - 11.29 kcal/mol), carvedilol (S = - 11.28 kcal/mol), mebeverine (S = - 11.14 kcal/mol), cepharanthine (S = - 11.06 kcal/mol), hydroxyzin (S = - 10.96 kcal/mol), astemizole (S = - 10.81 kcal/mol), sertindole (S = - 10.55 kcal/mol), and bepridil (S = - 10.47 kcal/mol) have higher inhibition activity than the candidate drug amiodarone (S = - 10.43 kcal/mol), making them better options for inhibition.

Keywords: ASMase; COVID-19; Ceramide; FIASMAs; Sphingomyelin.

 
Back
Top Bottom